These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21725605)

  • 1. Temozolomide decreases invasion of glioma stem cells by down-regulating TGF-β2.
    Zhang D; Jing Z; Qiu B; Wu A; Wang Y
    Oncol Rep; 2011 Oct; 26(4):901-8. PubMed ID: 21725605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEO212 Inhibits Migration and Invasion of Glioma Stem Cells.
    Marín-Ramos NI; Thein TZ; Cho HY; Swenson SD; Wang W; Schönthal AH; Chen TC; Hofman FM
    Mol Cancer Ther; 2018 Mar; 17(3):625-637. PubMed ID: 29440289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma.
    Tsen AR; Long PM; Driscoll HE; Davies MT; Teasdale BA; Penar PL; Pendlebury WW; Spees JL; Lawler SE; Viapiano MS; Jaworski DM
    Int J Cancer; 2014 Mar; 134(6):1300-10. PubMed ID: 23996800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells.
    Qiu ZK; Shen D; Chen YS; Yang QY; Guo CC; Feng BH; Chen ZP
    Chin J Cancer; 2014 Feb; 33(2):115-22. PubMed ID: 23958055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy.
    Gong X; Schwartz PH; Linskey ME; Bota DA
    Neurology; 2011 Mar; 76(13):1126-34. PubMed ID: 21346220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
    Zhao B; Bian EB; Li J; Li J
    J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temozolomide increases MHC-I expression via NF-κB signaling in glioma stem cells.
    Zhang D; Qiu B; Wang Y; Guan Y; Zhang L; Wu A
    Cell Biol Int; 2017 Jun; 41(6):680-690. PubMed ID: 28403532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoting oligodendroglial-oriented differentiation of glioma stem cell: a repurposing of quetiapine for the treatment of malignant glioma.
    Wang Y; Huang N; Li H; Liu S; Chen X; Yu S; Wu N; Bian XW; Shen HY; Li C; Xiao L
    Oncotarget; 2017 Jun; 8(23):37511-37524. PubMed ID: 28415586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest.
    Yu Q; Liu L; Wang P; Yao Y; Xue Y; Liu Y
    Cell Cycle; 2017 Jun; 16(11):1085-1092. PubMed ID: 28436750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy.
    Ulasov IV; Nandi S; Dey M; Sonabend AM; Lesniak MS
    Mol Med; 2011; 17(1-2):103-12. PubMed ID: 20957337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-Regulation of AQP4 Expression via p38 MAPK Signaling in Temozolomide-Induced Glioma Cells Growth Inhibition and Invasion Impairment.
    Chen Y; Gao F; Jiang R; Liu H; Hou J; Yi Y; Kang L; Liu X; Li Y; Yang M
    J Cell Biochem; 2017 Dec; 118(12):4905-4913. PubMed ID: 28569417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-125b inhibitor may enhance the invasion-prevention activity of temozolomide in glioblastoma stem cells by targeting PIAS3.
    Shi L; Wan Y; Sun G; Zhang S; Wang Z; Zeng Y
    BioDrugs; 2014 Feb; 28(1):41-54. PubMed ID: 23857508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas.
    Canella A; Welker AM; Yoo JY; Xu J; Abas FS; Kesanakurti D; Nagarajan P; Beattie CE; Sulman EP; Liu J; Gumin J; Lang FF; Gurcan MN; Kaur B; Sampath D; Puduvalli VK
    Clin Cancer Res; 2017 Oct; 23(20):6215-6226. PubMed ID: 28679777
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies.
    Hau P; Jachimczak P; Schlingensiepen R; Schulmeyer F; Jauch T; Steinbrecher A; Brawanski A; Proescholdt M; Schlaier J; Buchroithner J; Pichler J; Wurm G; Mehdorn M; Strege R; Schuierer G; Villarrubia V; Fellner F; Jansen O; Straube T; Nohria V; Goldbrunner M; Kunst M; Schmaus S; Stauder G; Bogdahn U; Schlingensiepen KH
    Oligonucleotides; 2007; 17(2):201-12. PubMed ID: 17638524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiles predicting the response to IFN-β and a combination of temozolomide and IFN-β in malignant gliomas.
    Yoshino A; Tashiro S; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Sano E; Tsumoto K
    Int J Oncol; 2011 Sep; 39(3):529-42. PubMed ID: 21805051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erianin induces ferroptosis in GSCs via REST/LRSAM1 mediated SLC40A1 ubiquitination to overcome TMZ resistance.
    Mansuer M; Zhou L; Wang C; Gao L; Jiang Y
    Cell Death Dis; 2024 Jul; 15(7):522. PubMed ID: 39039049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone morphogenetic protein 4 inhibits cell proliferation and induces apoptosis in glioma stem cells.
    Zhou Z; Sun L; Wang Y; Wu Z; Geng J; Miu W; Pu Y; You Y; Yang Z; Liu N
    Cancer Biother Radiopharm; 2011 Feb; 26(1):77-83. PubMed ID: 21355779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells.
    Zhuang D; Liu Y; Mao Y; Gao L; Zhang H; Luan S; Huang F; Li Q
    Int J Cancer; 2012 Jan; 130(2):309-18. PubMed ID: 21328340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation mediated silencing of miR-23b expression and its role in glioma stem cells.
    Geng J; Luo H; Pu Y; Zhou Z; Wu X; Xu W; Yang Z
    Neurosci Lett; 2012 Oct; 528(2):185-9. PubMed ID: 22982144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.